Abstract 5640: ZW439, a novel CLDN18.2-targeting pan-RAS inhibitor antibody drug conjugate for the treatment of RAS mutated pancreatic cancer
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Sam Lawn, Andrea Hernández Rojas, Vidhi Khanna, Jodi Wong, Ambroise Wu, Matthew Bonderud, Victoria Harman-McKenna, Taixiang Wang, Allysha Bissessur, Kaylee Wu, Manuel Lasalle, Vincent Fung, Chayne L. Piscitelli, Dunja Urosev, Luying Yang, Graham A. Garnett, Raffaele Colombo, Jamie R. Rich, Stuart D. Barnscher
Institution: Zymeworks (Canada)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148745983
Cites:
Cited by:
Related to: